The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,383.00
Bid: 1,398.00
Ask: 1,400.00
Change: -35.00 (-2.47%)
Spread: 2.00 (0.143%)
Open: 1,412.00
High: 1,433.00
Low: 1,383.00
Prev. Close: 1,418.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Indivior Rises After Raising Guidance

Fri, 15th Jan 2021 11:21

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.

----------

FTSE 100 - WINNERS

----------

Aveva Group, up 6.0%. The industrial software provider said third-quarter revenue was boosted by contract renewals. In the three months to December 31, organic constant currency revenue grew by over 26%, AVEVA said. Following the "strong quarter of renewals", Aveva's revenue in the nine months ended December grew 1.5% annually, on an organic constant currency basis. "The board remains confident in the ful-year outlook for Aveva. Notwithstanding the disruption seen to the trading environment in 2020, the trend towards the digitalisation of the industrial world is strong, and the board remains excited about the significant growth opportunities ahead," the company added.

----------

Entain up 1.2%. The Ladbrokes-owner is in talks to appoint Jette Nygaard-Andersen as chief executive, which would make her the first woman to run a listed UK gambling group, Sky News reported late Thursday. Sky News said Nygaard-Andersen's appointment was not concluded and would likely be announced in the coming weeks. Nygaard-Andersen is already a non-executive director on the board of Entain, previously known as GVC.

----------

FTSE 250 - WINNERS

----------

Indivior, up 9.0%. The drugmaker upped its revenue guidance for last year amid good performance from an opioid addiction treatment. Indivior raised its 2020 revenue guidance to a range between USD645 million and GBP650 million from a previous guided range of USD595 million to GBP620 million. The guidance upgrade came as the FTSE 250-listed drug manufacturer lifted its annual net revenue guidance for opioid addiction treatment Sublocade to between USD128 million to GBP130 million from its previous forecast of USD120 million to GBP125 million. It noted that Sublocade has seen benefits from modest stocking activity in the US in the fourth quarter.

----------

Meggitt, up 2.5%. The aerospace parts maker backed a 2021 recovery for the civil aerospace sector, though added that it will take some time for passenger numbers and aftermarket activity to rebound. For Covid-19-battered 2020, Meggitt expects revenue to fall by a quarter to GBP1.7 billion from GBP2.28 billion in 2019. Underlying operating profit is expected to land in the middle of a GBP180 million and GBP200 million range, so less than half the GBP402.8 million from 2019. The aerospace industry has been hit by air travel restrictions. Carriers suffered but so too did aftermarket service providers such as Meggitt. Promisingly however for Meggitt, net debt is expected to be below the GBP911.2 million level reported as of the end of 2019.

----------

FTSE 250 - LOSERS

----------

Petrofac, down 20%. UK's Serious Fraud Office late Thursday said a former executive of the oilfield services company pleaded guilty to three counts of bribery. The company noted on Friday that no charges were brought against Petrofac or any other officers and employees. In connection with the SFO's ongoing investigation into Petrofac, David Lufkin, its former global head of sales, on Thursday pleaded guilty at Westminster Magistrates' Court to three counts of bribery. "A small number of former Petrofac employees are alleged to have acted together with the individual concerned, although none have been charged. No current board member of Petrofac Ltd is alleged to have been involved," the company said on Friday. The offences relate to corrupt offers and payments made between 2012 and 2018 to influence the award of contracts to Petrofac in the United Arab Emirates worth approximately USD3.3 billion, the SFO said in a statement on Thursday.

----------

Babcock International Group, down 15%. The defence contractor said the civil aviation market continued to struggle in its third quarter, as the sector was hit by a resurgent Covid-19, with prospects for its traditionally bumper final stretch of trading also uncertain. And in a worrying update on a "review of contract profitability and balance sheet", the firm cautioned on possible write-downs. Underlying revenue for the nine months to December 31 was GBP3.40 billion, down 4.9% from GBP3.57 billion a year earlier. Babcock said that excluding disposals and foreign exchange, revenue was down 3%. Underlying operating profit for the nine months was down 37% annually to GBP202 million from GBP320 million, or down 34% excluding forex and disposals.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Gama Aviation, up 10%. The business aviation service provider said its US subsidiary Gama Aviation Engineering has acquired Trenton, New Jersey-based Jet East Aviation from East Coast Aviation for USD7.7 million. Gama said its subsidiary will pay USD7.7 million upfront from its existing resources, with a further USD1 million in deferred cash payable over two years. It also will assume USD3.2 million of business aviation aircraft maintenance provider Jet East's debt. Gama Aviation said the acquisition will "substantially" enhance its already extensive maintenance capability within the US, capturing "further market share with 15,000 active business aviation aircraft."

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

N Brown Group, down 14%. The clothing retailer said the pace of annual revenue decline slowed in the third quarter, but warned that global container issues and other problems in its supply chain have caused stock delivery delays of up to three weeks. Revenue in the third quarter ended January 2 was down 8.8% annually, slowed from the second quarter's 13% fall and the 22% plunge in the first. The period included the crucial Christmas trading. Product revenue fell 8.9% year-on-year in the third-quarter. For N Brown's five strategic brands - JD Williams, Simply Be, Ambrose Wilson, Jacamo and Home Essentials - there was just a 1.4% slip. However, other brands - which include online-focused Fashion World, plus Premier Man, House of Bath, Marisota, Oxendales, High & Mighty, Figleaves - saw a 26% third-quarter revenue plunge.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
20 Apr 2023 15:41

UK earnings, trading statements calendar - next 7 days

Friday 21 April 
Angle PLCFull Year Results
BHP Group LtdTrading Statement
Lookers PLCFull Year Results
Monday 24 April 
Brighton Pier Group PLCFull Year Results
CentralNic Group PLCTrading Statement
Checkit PLCFull Year Results
Egdon Resources PLCHalf Year Results
Keystone Law Group PLCFull Year Results
Lok'n Store Group PLCHalf Year Results
Novacyt SAFull Year Results
Tuesday 25 April 
AB Dynamics PLCHalf Year Results
Anglo American PLCTrading Statement
Associated British Foods PLCHalf Year Results
Avacta Group PLCFull Year Results
Banco Santander SAQ1 Results
Card Factory PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Corero Network Security PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
hVIVO PLCFull Year Results
IWG PLCTrading Statement
Jadestone Energy PLCFull Year Results
Next Fifteen Communications Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Oxford BioMedica PLCFull Year Results
Petrofac LtdFull Year Results
Quilter PLCTrading Statement
Resolute Mining LtdTrading Statement
RWS Holdings PLCTrading Statement
Travis Perkins PLCTrading Statement
WAG Payment Solutions PLCTrading Statement
Whitbread PLCFull Year Results
Wednesday 26 April 
1Spatial PLCFull Year Results
Biome Technologies PLCFull Year Results
Bunzl PLCQ1 Results
C4X Discovery Holdings PLCHalf Year Results
CRH PLCTrading Statement
Ecora Resources PLCTrading Statement
Frenkel Topping Group PLCFull Year Results
Fresnillo PLCTrading Statement
Gem Diamonds LtdTrading Statement
Glencore PLCTrading Statement
GSK PLCQ1 Results
Home REIT PLCHalf Year Results
Learning Technologies Group PLCFull Year Results
Man Group PLCTrading Statement
Pennant International Group PLCFull Year Results
RBG Holdings PLCFull Year Results
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Skillcast Group PLCFull Year Results
Smith & Nephew PLCTrading Statement
Standard Chartered PLCQ1 Results
Trifast PLCTrading Statement
Warpaint London PLCFull Year Results
Thursday 27 April 
AstraZeneca PLCTrading Statement
Barclays PLCQ1 Results
Brave Bison Group PLCFull Year Results
Capricorn Energy PLCFull Year Results
GCP Infrastructure Investments LtdTrading Statement
Howden Joinery Group PLCTrading Statement
Inchcape PLCTrading Statement
Indivior PLCQ1 Results
Inspecs Group PLCFull Year Results
J Sainsbury PLCFull Year Results
Lancashire Holdings LtdTrading Statement
Literacy Capital PLCTrading Statement
London Stock Exchange Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Schroders PLCTrading Statement
Spectris PLCQ1 Results
St James's Place PLCTrading Statement
Synairgen PLCFull Year Results
Taylor Wimpey PLCTrading Statement
Unilever PLCTrading Statement
WPP PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
2 Mar 2023 17:47

IN BRIEF: Indivior completes acquisition of Opiant Pharmaceuticals

Indivior PLC - North Chesterfield, Virginia-based pharmaceutical company - Completes the acquisition of Opiant Pharmaceuticals Inc. Says the acquisition will strengthen its addiction treatment and science portfolio through the addition of Opiant's late-stage assets, notably OPNT003, an investigational opioid overdose treatment.

Read more
20 Feb 2023 09:15

LONDON BROKER RATINGS: Berenberg lowers Spectris; RBC cuts Direct Line

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
16 Feb 2023 16:55

LONDON MARKET CLOSE: Records for FTSE and CAC but US PPI hits New York

(Alliance News) - Blue-chip benchmarks in London and Paris hit record highs on Thursday, with the FTSE 100 managing to cling to its daily gain, despite some weakness following US producer price data.

Read more
16 Feb 2023 12:19

CORRECT: LONDON MARKET MIDDAY: FTSE 100 stays above 8,000

(Correcting the GBPUSD quote).

Read more
16 Feb 2023 12:07

LONDON MARKET MIDDAY: FTSE 100 stays above 8,000 as Centrica jumps

(Alliance News) - Stock prices in London were higher at midday on Thursday, with London's flagship index still trading above the 8,000 mark on the back of strong performances from Centrica and Relx.

Read more
16 Feb 2023 10:10

CORRECT: Indivior shares down on swing to annual loss

(Correcting litigation provision is against 2022 results.)

Read more
16 Feb 2023 10:09

TOP NEWS: Indivior shares down on swing to annual loss

(Alliance News) - Indivior PLC on Thursday reported a swing to a full-year loss due to a provision for litigation, despite net revenue jumping by 14% due to growth in its Sublocade injection.

Read more
16 Feb 2023 08:49

LONDON MARKET OPEN: FTSE 100 tops 8,000; Centrica is star performer

(Alliance News) - Stock prices in London opened higher on Thursday, with London's blue-chip index pushing past the 8,000 mark once again, a day after it first broke the barrier.

Read more
16 Feb 2023 07:55

LONDON BRIEFING: Centrica, Indivior swing to loss; StanChart bullish

(Alliance News) - Stocks in London were set to open higher on Thursday, with the FTSE 100 called to push past the 8,000 mark again at the open.

Read more
16 Feb 2023 07:54

Indivior shares tumble as group sets aside $290m for US litigation

(Sharecast News) - Shares in pharmaceuticals business Indivior tumbled early on Thursday after the group revealed it had put aside $290.0m for ongoing litigation in the States.

Read more
9 Feb 2023 15:47

UK earnings, trading statements calendar - next 7 days

Friday 10 February 
Ince Group PLCFull Year Results (TBC)
Lancashire Holdings LtdFull Year Results
S&U PLCTrading Statement
Victrex PLCTrading Statement
Monday 13 February 
no events scheduled 
Tuesday 14 February 
Carr's Group PLCFull Year Results
Coca-Cola HBC AGFull Year Results
Plus500 LtdFull Year Results
Tui AGQ1 Results
UP Global Sourcing Holdings PLCTrading Statement
Wednesday 15 February 
Barclays PLCFull Year Results
Brunner Investment Trust PLCFull Year Results
Dunelm Group PLCHalf Year Results
Equipmake Holdings PLCHalf Year Results
Glencore PLCFull Year Results
Hargreaves Lansdown PLCHalf Year Results
Pan African Resources PLCHalf Year Results
Thursday 16 February 
Centrica PLCFull Year Results
Coca-Cola Europacific Partners PLCFull Year Results
Indivior PLCFull Year Results
MJ Gleeson PLCHalf Year Results
Moneysupermarket.com Group PLCFull Year Results
Relx PLCFull Year Results
Riverstone Credit Opportunities Income PLCFull Year Results
South32 LtdHalf Year Results
Standard Chartered PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
6 Feb 2023 16:32

Indivior announces expiry of waiting period for Opiant purchase

(Alliance News) - Indivior PLC has announced on Monday the expiration of the waiting period relating to its USD145 million purchase of Opiant Pharmaceuticals Inc.

Read more
7 Dec 2022 17:25

LONDON MARKET CLOSE: Pharma stocks fail to lift FTSE 100 in the green

(Alliance News) - Stocks in London closed in the red on Wednesday, despite a strong performance from pharmaceutical stocks, as investors digested a raft of economic data from both China and Europe.

Read more
7 Dec 2022 11:44

Indivior targets Nasdaq listing for spring 2023 as hails Sublocade

(Alliance News) - Indivior PLC on Wednesday said it aims to list on the Nasdaq in spring 2023 as it expects its injection Sublocade to reach peak annual net revenue of over USD1.5 billion.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.